A Call to Action in Long Term Care & Adult Care Facilities: Caring for People with Substance Use Disorder | GNYHCFA Webinar Series

A Call to Action in Long Term Care & Adult Care Facilities: Caring for People with Substance Use Disorder | GNYHCFA Webinar Series

The Greater New York Health Care Facilities Association (GNYHCFA) and the IPRO Quality Innovation Network-Quality Improvement Organization (QIN-QIO) are offering a series of webinars from October 2024 to January 2025 to educate, support, and encourage nursing homes...
U.S. Antibiotic Awareness Week 2024 | Working Together to Combat Antimicrobial Resistance

U.S. Antibiotic Awareness Week 2024 | Working Together to Combat Antimicrobial Resistance

The Center for Collaboration and Advancement in Pharmacy is excited to join the Centers for Disease Control and Prevention (CDC) in promoting the observance of U.S. Antibiotic Awareness Week (USAAW), raising awareness of the harms posed by antibiotic resistance, and...
A Call to Action in Long Term Care & Adult Care Facilities: Caring for People with Substance Use Disorder | GNYHCFA Webinar Series

Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Recorded Webinar Series

This recorded webinar series and podcasts is a collaboration of all of the Quality Innovation Network-Quality Improvement Organizations and provides strategies, interventions, and targeted solutions to ensure access to Medications for Opioid Use Disorder (MOUD)...
Updated Community Data Reports [Q1 2024]: Addressing Gaps, Achieving Growth and Quality Improvement

Updated Community Data Reports [Q1 2024]: Addressing Gaps, Achieving Growth and Quality Improvement

The Great Plains QIN team strives to improve healthcare quality and patient outcomes. We work with partners and community coalitions to identify areas for improvement, which include reducing avoidable hospital admissions and readmissions, including those caused by...
Access to Narcan in Nursing Homes Improves Overall Safety of Residents and Helps Mitigate Risk

Access to Narcan in Nursing Homes Improves Overall Safety of Residents and Helps Mitigate Risk

Opioid overdoses are on the rise among older adults, with a 300% increase in opioid overdose deaths among adults 65 years of age and older since the year 2000. Naloxone, also known by the brand name Narcan, is a life-saving medication that reverses opioid overdoses...
Addressing Substance Misuse Through the Lens of Social Determinants of Health (SDOH): Strategies for All Communities

Addressing Substance Misuse Through the Lens of Social Determinants of Health (SDOH): Strategies for All Communities

Join the Education Development Center and the North Dakota Behavioral Health & Human Services Center for a webinar,  Addressing Substance Misuse Through the Lens of Social Determinants of Health (SDOH): Strategies for All Communities. Tuesday, September 24, 2024 |...
The Hidden Connection Between Smoking and Opioids

The Hidden Connection Between Smoking and Opioids

A new analysis highlights the connection between smoking and opioid use. Data from the AHRQ Medical Expenditure Panel Survey (MEPS) and the National Health Interview Survey reveal that smokers are significantly more likely to use prescription opioids than non-smokers....
Join the Conversation: Motivational Interviewing to Reduce Falls in Older Adults

Join the Conversation: Motivational Interviewing to Reduce Falls in Older Adults

Falls threaten the safety and independence for older Americans and can create a heavy economic and personal burden. National Falls Prevention Awareness Week will be observed September 23 – 27, 2024. Throughout September we will work to bring attention to the issue of...
Simple Interventions For The Management Of Respiratory Illnesses Could Support Antimicrobial Stewardship Efforts To Reduce Antibiotic Use

Simple Interventions For The Management Of Respiratory Illnesses Could Support Antimicrobial Stewardship Efforts To Reduce Antibiotic Use

Researchers from the University of Southampton in the United Kingdom recently published results in The Lancet Respiratory Medicine journal from the Immune Defence trial. The study involved 13,799 adults at risk of adverse respiratory illness outcomes. Conducted at 332...